Form 8-K - Current report:
SEC Accession No. 0001193125-24-096227
Filing Date
2024-04-15
Accepted
2024-04-15 16:15:59
Documents
13
Period of Report
2024-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d814422d8k.htm   iXBRL 8-K 27341
  Complete submission text file 0001193125-24-096227.txt   154467

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crgx-20240415.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crgx-20240415_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crgx-20240415_pre.xml EX-101.PRE 11702
16 EXTRACTED XBRL INSTANCE DOCUMENT d814422d8k_htm.xml XML 3777
Mailing Address 1900 ALAMEDA DE LAS PULGAS SUITE 350 SAN MATEO CA 94403
Business Address 1900 ALAMEDA DE LAS PULGAS SUITE 350 SAN MATEO CA 94403 650-379-6143
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

EIN.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 24844826
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)